SCHEMBL29695366

SCHEMBL29695366

CC1NC(=O)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 6/20 0.49
HTR2A P28223 2/20 0.49
HTR2C P28335 2/20 0.49
HTR2B P41595 2/20 0.49
PARP1 P09874 1/20 0.49
PBRM1 Q86U86 1/20 0.49
TSHR P16473 2/20 0.48
HSD17B10 Q99714 3/20 0.47
CYP1A2 P05177 2/20 0.45
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GSK3B P49841 1/20 0.41
MKNK2 Q9HBH9 2/20 0.40
MKNK1 Q9BUB5 1/20 0.40
NPC1 O15118 1/20 0.40
KMT2A Q03164 1/20 0.40
BRPF1 P55201 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1708832 1.00 TNKS2 (0.49) TNKS2HTR2AHTR2CHTR2BPARP1
SCHEMBL31667419 1.00 TNKS2 (0.49) TNKS2HTR2AHTR2CHTR2BPARP1
SCHEMBL19573960 1.00 TNKS2 (0.49) TNKS2HTR2AHTR2CHTR2BPARP1
SCHEMBL19573959 1.00 TNKS2 (0.49) TNKS2HTR2AHTR2CHTR2BPARP1
SCHEMBL20012844 0.88 TNKS2 (0.42) TNKS2HTR2AHTR2CHTR2BPARP1
SCHEMBL29031895 0.80 MAPT (0.41) TNKS2HTR2AHTR2CHTR2BPARP1
SCHEMBL15256932 0.79 TNKS2 (0.46) TNKS2HTR2AHTR2CHTR2BPARP1
SCHEMBL8293271 0.78 TSHR (0.48) TNKS2HTR2BPBRM1TSHRHSD17B10
SCHEMBL12219994 0.76 MKNK2 (0.40) TSHRHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL17797168 0.75 HSD17B10 (0.49) TNKS2HTR2AHTR2CHTR2BPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3606921-B1 NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA. INVENTIVA (FR) 2022-06-01 EP claimed